Showing results (231-240 of 268) with videos related to
Sort By:
Pageof 27
Internal Medicine (Tokyo, Japan)|August 1, 1992
Beta(+)-thalassemia with hemochromatosisM Uchihara, T Nouchi, T Harano, et al.Journal of Medical Virology|May 1, 1995
Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liverN Sakamoto, N Enomoto, M Kurosaki, et al.International Journal of Colorectal Disease|January 11, 2001
Flat-elevated and depressed, subtypes of flat early colorectal cancers, should be distinguished by their pathological featuresM Sakashita, N Aoyama, S Maekawa, et al.Journal of Hepatology|January 1, 1993
Detection of hepatitis C viral RNA in sporadic acute non-A, non-B hepatitis by polymerase chain reaction. Its usefulness for the early diagnosis of seronegative infectionN Sakamoto, C Sato, H Haritani, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1987
[A case of pericarditis carcinomatosa showing good response following local transfer of lymphokine-activated killer (LAK) cells]Y Ueno, Y Kohgo, Y Sasagawa, et al.European Journal of Cancer (Oxford, England : 1990)|February 13, 2001
Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological featuresM Sakashita, N Aoyama, R Minami, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Marked clinical improvement in patients with hepatocellular carcinoma by surgical removal of extended tumor mass in right atrium and pulmonary arteriesN Masaki, S Hayashi, T Maruyama, et al.The American Journal of Gastroenterology|October 16, 1999
Efficacy of endoscopic clipping for bleeding gastroduodenal ulcer: comparison with topical ethanol injectionK Nagayama, J Tazawa, Y Sakai, et al.Surgery Today|January 1, 1997
A comparison of open and laparoscopic cholecystectomy for patients with cirrhosisH Saeki, D Korenaga, H Yamaga, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 19, 2003
Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapyY Watanabe, N Aoyama, D Shirasaka, et al.Pageof 27